[Ip-health] Stat+: Pharma enlists a congressional ally to persuade U.S. trade officials to lean on Colombia

Andrew Goldman andrew.goldman at keionline.org
Wed Mar 7 13:28:23 PST 2018


The letter that Rep. Lance sent is available here:
http://freepdfhosting.com/78f7b2c38c.pdf

https://www.statnews.com/pharmalot/2018/03/07/pharma-colombia-trade-patents-prices/?utm_source=STAT+Newsletters&utm_campaign=d7644c92ef-Pharmalot&utm_medium=email&utm_term=0_8cab1d7961-d7644c92ef-149703293

Pharma enlists a congressional ally to persuade U.S. trade officials to
lean on Colombia

By ED SILVERMAN @Pharmalot

MARCH 7, 2018

The pharmaceutical industry is doubling down on its campaign to force
Colombia to alter its policies toward pricing and patents for medicines by
enlisting the support of a congressional ally.

Over the past month, industry groups urged U.S. trade officials to place
Colombia on a list of countries that purportedly fail to enforce
intellectual property rights. Trade officials responded by warning Colombia
that changes are needed prior to an upcoming meeting to discuss membership
in the Organization for Economic Cooperation and Development, an
intergovernmental trade group.

Now, on the eve of Thursday’s meeting, Rep. Leonard Lance (R-N.J.) wrote to
the Office of the U.S. Trade Representative to say there are issues that
Colombia “must address” before the country should be considered for OECD
membership. And he pointed to the same complaints that were raised recently
by BIO and PhRMA.

<snip>

--
Andrew S. Goldman
Counsel, Policy and Legal Affairs
Knowledge Ecology International
andrew.goldman at keionline.org // www.twitter.com/ASG_KEI
tel.: +1.202.332.2670 <(202)%20332-2670>
www.keionline.org


More information about the Ip-health mailing list